Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Halpern

Showing results (191-200 of 250) with videos related to

Pageof 25
Sort By:
Transplantation and Cellular Therapy|September 15, 2025
Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective StudyRachel B Salit, Xinyi Fan, Ted A Gooley, et al.
The New England Journal of Medicine|April 29, 1976
Letter: Patient with defect in leucine metabolismK Faull, P Bolton, B Halpern, et al.
Journal of Drug Assessment|July 24, 2018
Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)Utkarsh H Acharya, Anna B Halpern, Qian Vicky Wu, et al.
Journal of Electron Microscopy|August 27, 2005
Nanostructure of Er3+ doped silicatesNan Yao, Kirk Hou, Christopher D Haines, et al.
American Journal of Human Genetics|September 1, 1980
Antenatal diagnosis of glutaric acidemiaS I Goodman, D A Gallegos, C J Pullin, et al.
Leukemia|July 31, 2023
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasmsLauren Shih, Megan Othus, Kelda Schonhoff, et al.
JCO Oncology Practice|April 3, 2025
Predictors of Cardiac Recovery in Adults With AML Who Develop Heart Failure During TreatmentMatthew Wu, Kathryn Russell, Carole M Shaw, et al.
Biomedical Mass Spectrometry|March 1, 1981
Two new sulphur-containing amino acids in manR J Truscott, D Malegan, E McCairns, et al.
Leukemia|March 26, 2016
Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemiaY Zhou, M Othus, D Araki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?Daisuke Araki, Brent L Wood, Megan Othus, et al.
Pageof 25

Showing results (191-200 of 250) with videos related to

Sort By:
Pageof 25
Transplantation and Cellular Therapy|September 15, 2025
Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective StudyRachel B Salit, Xinyi Fan, Ted A Gooley, et al.
The New England Journal of Medicine|April 29, 1976
Letter: Patient with defect in leucine metabolismK Faull, P Bolton, B Halpern, et al.
Journal of Drug Assessment|July 24, 2018
Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)Utkarsh H Acharya, Anna B Halpern, Qian Vicky Wu, et al.
Journal of Electron Microscopy|August 27, 2005
Nanostructure of Er3+ doped silicatesNan Yao, Kirk Hou, Christopher D Haines, et al.
American Journal of Human Genetics|September 1, 1980
Antenatal diagnosis of glutaric acidemiaS I Goodman, D A Gallegos, C J Pullin, et al.
Leukemia|July 31, 2023
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasmsLauren Shih, Megan Othus, Kelda Schonhoff, et al.
JCO Oncology Practice|April 3, 2025
Predictors of Cardiac Recovery in Adults With AML Who Develop Heart Failure During TreatmentMatthew Wu, Kathryn Russell, Carole M Shaw, et al.
Biomedical Mass Spectrometry|March 1, 1981
Two new sulphur-containing amino acids in manR J Truscott, D Malegan, E McCairns, et al.
Leukemia|March 26, 2016
Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemiaY Zhou, M Othus, D Araki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?Daisuke Araki, Brent L Wood, Megan Othus, et al.
Pageof 25